首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: Comparison of [11C]MeDAS, [11C]CIC and [11C]PIB
【24h】

PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: Comparison of [11C]MeDAS, [11C]CIC and [11C]PIB

机译:在多发性硬化症大鼠模型中局灶性脱髓鞘和髓鞘再生的PET成像:[11C] MeDAS,[11C] CIC和[11C] PIB的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: In this study, we compared the ability of [11C]CIC, [11C]MeDAS and [11C]PIB to reveal temporal changes in myelin content in focal lesions in the lysolecithin rat model of multiple sclerosis. Pharmacokinetic modelling was performed to determine the best method to quantify tracer uptake. Methods: Sprague-Dawley rats were stereotactically injected with either 1 % lysolecithin or saline into the corpus callosum and striatum of the right brain hemisphere. Dynamic PET imaging with simultaneous arterial blood sampling was performed 7 days after saline injection (control group), 7 days after lysolecithin injection (demyelination group) and 4 weeks after lysolecithin injection (remyelination group). Results: The kinetics of [11C]CIC, [11C]MeDAS and [11C]PIB was best fitted by Logan graphical analysis, suggesting that tracer binding is reversible. Compartment modelling revealed that all tracers were fitted best with the reversible two-tissue compartment model. Tracer uptake and distribution volume in lesions were in agreement with myelin status. However, the slow kinetics and homogeneous brain uptake of [11C]CIC make this tracer less suitable for in vivo PET imaging. [11C]PIB showed good uptake in the white matter in the cerebrum, but [11C]PIB uptake in the cerebellum was low, despite high myelin density in this region. [ 11C]MeDAS distribution correlated well with myelin density in different brain regions. Conclusion: This study showed that PET imaging of demyelination and remyelination processes in focal lesions is feasible. Our comparison of three myelin tracers showed that [11C]MeDAS has more favourable properties for quantitative PET imaging of demyelinated and remyelinated lesions throughout the CNS than [11C]CIC and [ 11C]PIB.
机译:目的:在这项研究中,我们比较了[11C] CIC,[11C] MeDAS和[11C] PIB在多发性硬化症的溶血卵磷脂大鼠模型中揭示局灶性病变中髓磷脂含量随时间变化的能力。进行了药代动力学建模,以确定量化示踪剂摄取的最佳方法。方法:向Sprague-Dawley大鼠立体定向注射1%溶血卵磷脂或生理盐水至右脑半球的call体和纹状体。注射盐水后7天(对照组),溶血卵磷脂注射后7天(脱髓鞘组)和溶血卵磷脂注射后4周(再髓鞘形成组)进行动态PET成像并同时进行动脉血采样。结果:Logan图形分析最适合[11C] CIC,[11C] MeDAS和[11C] PIB的动力学,表明示踪剂结合是可逆的。隔室模型显示,所有示踪剂均最适合可逆的两组织隔室模型。示踪剂在皮损中的摄取和分布量与髓磷脂状态一致。但是,[11C] CIC的缓慢动力学和均匀的脑部吸收使该示踪剂不适用于体内PET成像。 [11C] PIB在大脑中的白质中显示出良好的摄取,但是,尽管该区域中的髓磷脂密度很高,但[11C] PIB在小脑中的摄取却较低。 [11C] MeDAS分布与不同大脑区域的髓磷脂密度密切相关。结论:这项研究表明,PET成像对局灶性病变的脱髓鞘和髓鞘再生过程是可行的。我们对三种髓鞘示踪剂的比较显示,与[11C] CIC和[11C] PIB相比,[11C] MeDAS对整个CNS中的脱髓鞘和再髓鞘病变的定量PET成像具有更有利的性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号